CD163 and lymphoma: Alternatively, we hypothesized that it may depend on CSF1/CSF1R pathway activation, as in solid cancers [15] and lymphoma [27,28], which was confirmed by the abrogation of CD163 expression induced by AML CM supplemented with GW2580 or PLX3397 (Figure 1D).